A clinical effect to study the effect of the drug Pavazha Silasathu parpam in patients having uncomplicated cystitis ( Azhal Neerchurukku)

Phase II non randomized open clinical study of Siddha medicine Pavazha Silasathu parpam for Azhal Neerchurukku Churruku ( uncomplicated cystitis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/028822

Enrollment

Registered

2020-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A488- Other specified bacterial diseases

Interventions

Intervention1: Pavazha Silasathu parpam: 130mg of Pavazha Silasathu parpam is administered orally twice a day with butter for 15 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Hematuria Dysuria Frequency of micturition Oliguria Patients having supra pubic pain Foul / cloudy smelling urine

Exclusion criteria

Exclusion criteria: Pregnant/ Lactating women Pyelonephritis Catheterized patients Vaginitis STD Prostitis Kidney stones

Design outcomes

Primary

Measure	Time frame
Primary outcome is assessed by reduction of dysuria Frequency of micturition suprapubic pain Disappearance of bacteria in culture Timepoint: Primary outcome is assessed by after four weeks of administration of the medicine	—

Secondary

Measure	Time frame
Disappearance of bacteria in cultureTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Maha Sundari Sudha M

Government Siddha Medical college

mmsankar2000@gmail.com9445716802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026